Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.

Maron BJ, Seidman CE, Ackerman MJ, Towbin JA, Maron MS, Ommen SR, Nishimura RA, Gersh BJ.

Circ Cardiovasc Genet. 2009 Feb;2(1):81-5; discussion 86. doi: 10.1161/CIRCGENETICS.108.788703. No abstract available.

PMID:
20031569
[PubMed - indexed for MEDLINE]
Free Article
2.

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Hershberger RE, Cowan J, Morales A, Siegfried JD.

Circ Heart Fail. 2009 May;2(3):253-61. doi: 10.1161/CIRCHEARTFAILURE.108.817346. Review.

PMID:
19808347
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The case for myocardial ischemia in hypertrophic cardiomyopathy.

Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, Camici PG.

J Am Coll Cardiol. 2009 Aug 25;54(9):866-75. doi: 10.1016/j.jacc.2009.04.072.

PMID:
19695469
[PubMed - indexed for MEDLINE]
Free Article
4.

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.

Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H.

Circ Res. 2009 Jul 31;105(3):219-22. doi: 10.1161/CIRCRESAHA.109.202440. Epub 2009 Jul 2.

PMID:
19574547
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, Seidman J, Seidman CE.

JAMA. 2009 Mar 25;301(12):1253-9. doi: 10.1001/jama.2009.371.

PMID:
19318653
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ.

Circulation. 2008 Oct 7;118(15):1541-9. doi: 10.1161/CIRCULATIONAHA.108.781401. Epub 2008 Sep 22.

PMID:
18809796
[PubMed - indexed for MEDLINE]
Free Article
7.

Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy.

Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F.

Mayo Clin Proc. 2008 Jun;83(6):630-8. doi: 10.4065/83.6.630.

PMID:
18533079
[PubMed - indexed for MEDLINE]
8.

The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.

Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y.

Hum Mutat. 2008 Aug;29(8):992-1006. doi: 10.1002/humu.20748. Review.

PMID:
18470943
[PubMed - indexed for MEDLINE]
9.

Shared genetic causes of cardiac hypertrophy in children and adults.

Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE.

N Engl J Med. 2008 May 1;358(18):1899-908. doi: 10.1056/NEJMoa075463. Epub 2008 Apr 9.

PMID:
18403758
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Genetic determinants of cardiac hypertrophy.

Marian AJ.

Curr Opin Cardiol. 2008 May;23(3):199-205. doi: 10.1097/HCO.0b013e3282fc27d9. Review.

PMID:
18382207
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.

Keren A, Syrris P, McKenna WJ.

Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):158-68. doi: 10.1038/ncpcardio1110. Epub 2008 Jan 29. Review. Erratum in: Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):747.

PMID:
18227814
[PubMed - indexed for MEDLINE]
12.

Management of symptoms in hypertrophic cardiomyopathy.

Fifer MA, Vlahakes GJ.

Circulation. 2008 Jan 22;117(3):429-39. doi: 10.1161/CIRCULATIONAHA.107.694158. Review. No abstract available.

PMID:
18212300
[PubMed - indexed for MEDLINE]
Free Article
13.

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.

Miller MA, Gomes JA, Fuster V.

Nat Clin Pract Cardiovasc Med. 2007 Dec;4(12):667-76. Review.

PMID:
18033231
[PubMed - indexed for MEDLINE]
14.

Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?

Bos JM, Ommen SR, Ackerman MJ.

Curr Opin Cardiol. 2007 May;22(3):193-9. Review.

PMID:
17413275
[PubMed - indexed for MEDLINE]
15.
16.

Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.

Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF, Shete S, Roberts R, Willerson JT, Marian AJ.

Circ Res. 2007 Mar 30;100(6):766-8. Epub 2007 Mar 8.

PMID:
17347475
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).

European Heart Rhythm Association; Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL; American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines.

J Am Coll Cardiol. 2006 Sep 5;48(5):e247-346. No abstract available.

PMID:
16949478
[PubMed - indexed for MEDLINE]
Free Article
18.

ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society.

Circulation. 2006 Aug 15;114(7):e257-354. No abstract available. Erratum in: Circulation. 2007 Aug 7;116(6):e138.

PMID:
16908781
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical genetics in cardiology.

Charron P.

Heart. 2006 Aug;92(8):1172-6. Review. No abstract available.

PMID:
16844882
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.

Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ.

Circulation. 2006 Jul 18;114(3):216-25. Epub 2006 Jul 10.

PMID:
16831987
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk